VAN SCOYOC ASSOCIATES

Lobbying for QUVA PHARMA, INC. · 503B outsourcing facility

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 19, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

Texas

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Pharmacy

Outsourcing facilities regulated under Section 503B under the Federal Food, Drug, and Cosmetic Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.